Arcadia Biosciences Inc (NASDAQ:RKDA) Short Interest Up 18.3% in July

Arcadia Biosciences Inc (NASDAQ:RKDA) was the recipient of a significant growth in short interest in July. As of July 31st, there was short interest totalling 89,800 shares, a growth of 18.3% from the June 30th total of 75,900 shares. Based on an average daily trading volume, of 1,000,000 shares, the short-interest ratio is presently 0.1 days. Approximately 2.8% of the shares of the stock are sold short.

A number of brokerages recently weighed in on RKDA. HC Wainwright restated a “buy” rating on shares of Arcadia Biosciences in a report on Monday. ValuEngine upgraded shares of Arcadia Biosciences from a “sell” rating to a “hold” rating in a report on Thursday, August 1st. Finally, National Securities restated a “buy” rating and set a $15.00 target price on shares of Arcadia Biosciences in a report on Thursday, May 9th.

Arcadia Biosciences stock traded up $0.96 during midday trading on Wednesday, reaching $7.05. The stock had a trading volume of 10,441,700 shares, compared to its average volume of 1,202,870. The firm has a fifty day moving average of $3.10. Arcadia Biosciences has a twelve month low of $1.82 and a twelve month high of $10.40. The company has a debt-to-equity ratio of 2.80, a quick ratio of 6.19 and a current ratio of 6.26. The firm has a market cap of $28.26 million, a price-to-earnings ratio of -1.32 and a beta of -2.01.

Institutional investors have recently bought and sold shares of the stock. Citadel Advisors LLC acquired a new position in Arcadia Biosciences in the 2nd quarter worth approximately $32,000. Morgan Stanley boosted its stake in Arcadia Biosciences by 162,800.0% in the 2nd quarter. Morgan Stanley now owns 81,450 shares of the basic materials company’s stock worth $250,000 after purchasing an additional 81,400 shares during the period. Finally, Vanguard Group Inc. boosted its stake in Arcadia Biosciences by 47.1% in the 2nd quarter. Vanguard Group Inc. now owns 117,059 shares of the basic materials company’s stock worth $359,000 after purchasing an additional 37,472 shares during the period. 3.11% of the stock is owned by hedge funds and other institutional investors.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc, an agricultural food ingredient company, develops and commercializes health and nutrition ingredient traits worldwide. The company offers a suite of agricultural productivity traits, including nitrogen use efficiency, water use efficiency and drought tolerance, salinity tolerance, and herbicide tolerance traits.

See Also: Stochastic Momentum Index (SMI)

Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with's FREE daily email newsletter.